BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-1.13%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.86B
AUM Growth
+$5.86B
(+222%)
Cap. Flow
+$4.03B
Cap. Flow
% of AUM
68.76%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
219
New
83
Increased
86
Reduced
22
Closed
16
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$492M |
| 2 |
Incyte
INCY
|
$310M |
| 3 |
Neurocrine Biosciences
NBIX
|
$298M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$239M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$239M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$29.2M |
| 2 |
Cencora
COR
|
$19.9M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$16.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$14.7M |
| 5 |
Illumina
ILMN
|
$10.9M |
Sector Composition
| 1 | Healthcare | 94.72% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.42% |
| 4 | Financials | 0.06% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Q32 Bio
QTTB
$20.9M
| $27.4M | 0.47% | +1,402,122 | New | +$27.4M |
|
52
Baxter International
BAX
$12.7B
| $25.7M | 0.44% | 314,237 +21,063 | +7% | +$1.73M |
|
53
HCA Healthcare
HCA
$94.5B
| $25.2M | 0.43% | 186,745 +126,348 | +209% | +$17.1M |
|
54
DexCom
DXCM
$29.5B
| $24.7M | 0.42% | 165,136 +33,990 | +26% | +$5.09M |
|
|
HRC
55
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $24.4M | 0.42% | 233,198 +30,110 | +15% | +$3.15M |
|
|
AMED
56
DELISTED
Amedisys
AMED
| $21.2M | 0.36% | 174,310 +140,654 | +418% | +$17.1M |
|
|
GTHX
57
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $20.6M | 0.35% | +671,925 | New | +$20.6M |
|
58
LivaNova
LIVN
$3.08B
| $19.1M | 0.33% | 265,666 +98,710 | +59% | +$7.1M |
|
59
Evolent Health
EVH
$1.12B
| $18.7M | 0.32% | 2,349,000 +940,763 | +67% | +$7.48M |
|
60
CareDx
CDNA
$727M
| $17.7M | 0.3% | 492,008 +60,440 | +14% | +$2.18M |
|
61
Thermo Fisher Scientific
TMO
$186B
| $16.7M | 0.29% | 57,024 +18,166 | +47% | +$5.34M |
|
|
FIT
62
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $16.3M | 0.28% | 3,696,530 +427,596 | +13% | +$1.88M |
|
63
QuidelOrtho
QDEL
$1.95B
| $15.9M | 0.27% | 268,470 +44,890 | +20% | +$2.66M |
|
64
Insmed
INSM
$28.8B
| $15.9M | 0.27% | 620,459 -38,975 | -6% | -$998K |
|
|
AVDR
65
DELISTED
Avedro, Inc Common Stock
AVDR
| $15.8M | 0.27% | 804,379 +54,379 | +7% | +$1.07M |
|
66
Supernus Pharmaceuticals
SUPN
$2.53B
| $15.5M | 0.26% | 467,000 +176,000 | +60% | +$5.82M |
|
|
GNMK
67
DELISTED
GenMark Diagnostics, Inc
GNMK
| $15.3M | 0.26% | 2,353,067 | – | – |
|
|
CHNG
68
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $14.6M | 0.25% | +1,000,000 | New | +$14.6M |
|
69
Omnicell
OMCL
$1.5B
| $14.3M | 0.24% | 166,715 +22,876 | +16% | +$1.97M |
|
|
WMGI
70
DELISTED
Wright Medical Group Inc
WMGI
| $14.3M | 0.24% | 478,495 -95,100 | -17% | -$2.84M |
|
71
iRhythm Technologies
IRTC
$5.46B
| $14.1M | 0.24% | 178,848 +61,087 | +52% | +$4.83M |
|
72
Quanterix
QTRX
$211M
| $13.4M | 0.23% | 397,569 +48,210 | +14% | +$1.63M |
|
73
HUTCHMED
HCM
$2.58B
| $13.2M | 0.22% | 598,310 | – | – |
|
|
HMSY
74
DELISTED
HMS Holdings Corp.
HMSY
| $12.9M | 0.22% | 398,442 +107,465 | +37% | +$3.48M |
|
75
Teleflex
TFX
$5.59B
| $12.2M | 0.21% | 36,766 +17,018 | +86% | +$5.64M |
|